Further expansion at Randox COVID labs with recruitment drive for 400 new staff
Randox Laboratories is hiring a further 400 new staff in support of its COVID-19 testing operations at the Randox Science Park in Antrim.
The healthcare diagnostics company has increased its workforce by over 850 staff since the beginning of the pandemic and continues to recruit to enhance its laboratory capacity within the UK’s National COVID-19 Testing Programme, and for those requiring PCR testing before travel.
Vacancies are available across science, accessioning, manufacturing and customer support.
Dr Peter FitzGerald, Managing Director of Randox Laboratories, commented;
“With our headquarters in the Randox Science Park in County Antrim, we are fortunate to benefit from Northern Ireland’s incredible talent pool across a variety of disciplines, and so many have already responded to our call for support in fighting the coronavirus.
“Our staff have risen to the challenge this pandemic has created, been incredibly resourceful and flexible, and pulled together as a team to make an impact in the fight against COVID-19. They are our best asset and we are very proud of their efforts.”
Earlier this month Randox reached a significant testing milestone, with 12 million tests completed since its testing began.
Thanks to significant private investment, Randox’s testing capacity, which in March 2020 was just 150 tests per day, has now increased to 120,000 daily COVID tests, making Randox the most productive laboratory in the UK and Ireland.
Dr FitzGerald continued;
“The completion of over 12 million gold-standard PCR tests for the UK’s National Testing Programme, representing approximately 21% of all PCR tests executed in the UK, is testament to the hard work and dedication of all our staff.
“We continue to play a vital role in the national network of testing, which is of critical importance and remains a key part of the response to COVID-19 – not only to identify outbreaks, isolate cases and prevent further spread, but also to assist with a return to social and economic normality.”
Want to know more?
Contact us or visit Randox Careers
Randox has today opened a new Covid-19 testing facility with Belfast City Airport.
The test centre, purpose-built by leading Belfast building firm H&J Martin, offers quick and affordable PCR and antigen (lateral flow) tests, with its opening coinciding with the resumption of international flights from Belfast City Airport.
Airport Operations Manager, Judith Davis, explained:
“Flights have resumed today from Belfast City to Amsterdam Schiphol Airport with our airline partner KLM, which is another positive step as airlines across the world rebuild and restart their networks.
“Currently the Dutch Government requires all passengers entering the Netherlands to have taken and returned a negative result from both a PCR and an antigen (lateral flow) test. Providing this service on-site is the ultimate convenience for our passengers, which is something we pride ourselves on and continually strive to enhance.”
PCR tests by Randox at Belfast City Airport are available at the reduced price of £85, with antigen tests available for £45. Judith details further the benefits this offers the people of Northern Ireland;
“These tests, which must be pre-booked, aren’t just reserved for passengers flying from Belfast City Airport but are also available for non-flying members of the general public.
“The fact that results from the antigen tests are returned within one hour, and a digital ‘safe to fly’ certificate is issued directly to the passenger’s mobile device, is also another huge bonus and adds a further layer of convenience for our customers who need to travel.”
Speaking of the partnership with Belfast City Airport, and the importance of this test facility at the UK and Ireland’s most convenient airport, Project Manager at Randox, Sophie Boyd, said:
“Randox are committed to supporting those wishing to undertake international travel, including holidays, and the travel industry. In doing so we believe we will be improving wellbeing and supporting employment.
“As flights resume and we open the Randox Health Travel Centre at Belfast City Airport we will provide competitive, effective and efficient testing to support the travelling public.
“We are delighted to be working in partnership with Belfast City Airport and wish them every success in re-establishing their international travel links.”
(l-r John McConnell of H&J Martin, Judith Davis, Airport Operations Manager, and Sophie Boyd, Project Manager at Randox)
This Covid-19 testing facility is the latest health and safety measure to be implemented at Belfast City Airport, which was the first airport in Northern Ireland to achieve the ACI’s Airport Health Accreditation for its extensive, thorough, and best-in-class passenger safety procedures.
“The wellbeing of our passengers and staff remains of paramount importance to us and those travelling to the airport can be reassured that stringent measures are in place for their safety,” Judith concluded.
Covid-19 testing at the Airport is available by appointment only and slots can be booked now at https://booking.randox.com/
For further information on Covid testing at Belfast City Airport please contact the Randox Covid Customer Support team on firstname.lastname@example.org or 0800 2545 201.
For press enquiries please contact Amy Millar in the Randox PR team on email@example.com or 028 9442 2413
Want to know more?
Contact us or visit the Randox Health Travel Centre booking page
Related COVID-19 Products and Services
TEST TO RELEASE
Cross Border Collaboration delivers International Award for High Design Quality: Randox Discovery, The Benchtop Lab receives Red Dot Design Award
The Randox Discovery, an exciting and unique diagnostic analyser which can consolidate molecular and immunoassay testing on one compact benchtop platform, has received the 2021 Red Dot Award for High Design Quality.
Red Dot, which has become established as one of the top profile product design awards has roots dating back as far as 1955 and determines the best products created each year. Recognised as one of the largest global product competitions for innovation excellence, this sought-after seal for quality design attracts submissions from over 50 countries, across 49 different categories including medical devices and technology.
Dr Stuart Jackson, Randox Project Design Engineer, commented;
“Randox are delighted to have achieved the Red Dot design award, the culmination of five years of development and coordination of engineering design teams spanning two continents. The Discovery is a particularly unique innovation capable of automating Randox Biochip molecular diagnostics assays, from sample lysis and end-point PCR to multiplexing detection, with accessibility and ease-of-use at the forefront of the design.”
Dolmen were briefed by the Randox team to develop a creative and dynamic way to showcase the cutting-edge inner workings of the Discovery. Essentially, to turn the magic of the machine into a piece of theatre; not just a tool, but the centre of attention, a focal point for the lab that has excellent usability and accessibility throughout. Dolmen and Randox collaborated closely to deliver a revolutionary instrument that, amongst its many abilities, is a COVID-19 diagnostic analyser that is the first of its kind.
Chris Murphy, CEO and Design Director, Dolmen Design and Innovation, commented;
“We are delighted that our collaboration with Randox has delivered another Red Dot design award for our team. Randox as a team truly value the power of design and how it can deliver better outcomes for end users. It is also wonderful to see our designs delivering positive change at the frontline of the COVID pandemic. This project was hugely collaborative, and we look forward to more collaborations in the future.”
What makes the Discovery special is its ability to conduct the full testing process, inclusive of sample preparation techniques such as extraction, purification, amplification and detection, in one highly intelligent, fully integrated space. The preparation of COVID-19 samples before testing was once lengthy and time-consuming, requiring a separate, sterilized laboratory for each stage, but can now be conducted on-board and by the fully automated Discovery platform, allowing a single operator to run multiple molecular tests simultaneously.
Combining almost 40 years of diagnostics into one platform, bringing multiple labs into one the COVID-19 diagnostic analyser is the first of its kind to combine sample preparation techniques and Biochip Technology.
Professor Dr. Peter Zec, Red Dot CEO, commented;
“The winners of the Red Dot Award: Product Design 2021 were particularly impressive this year. The design of their products is excellent, in terms of both the aesthetic and the functionality. It’s not easy to prevail in such a strong field of competitors and to win over our jury. Consequently, I want to congratulate the laureates very sincerely on their success.”
For further information please email firstname.lastname@example.org
Want to know more?
Contact us or visit our find out more about the Randox Discovery
COVID 19 Product Overview
COVID 19 QPCR ASSAY
VIRAL RNA EXTRACTION KIT
Tuesday 13th April 2021
Randox Covid-19 PCR Tests Reduced to £60 for Overseas Travel
Randox, the UK’s largest Covid-19 PCR testing provider, today announced their support for UK holidaymakers seeking trips overseas by reducing the cost of PCR tests to support travel to £60 per test. Currently PCR tests can cost from £100 each, and often much more.
This announcement comes hot on the heels of the Department for Transport’s plans to open-up overseas travel, potentially from as early as 17th May, but dependent on PCR testing pre-departure and on return. Specific PCR testing requirements will be based on the grading of destination countries within a green, amber and red traffic light system.
Last week UK transport secretary Grant Shapps sought to lower the cost of coronavirus testing to help encourage foreign holidays this summer – and Randox have led the response.
Dr Peter FitzGerald, Randox Managing Director said;
“In recognition of the needs of both the travel industry and the British public at this unprecedented time, Randox will reduce the all-inclusive cost of PCR testing for those in the UK undertaking international travel to £60 per test. We can see the pressures faced by the both the travel industry and the general public and are committed to effective and economical testing to support holidaymakers and those undertaking international travel.
The £60 PCR test is based on a testing kit ordered, on-line, for home sample collection with the sample returned to the laboratory for testing. The cost is inclusive of VAT and logistics. In order to achieve the £60 price, which is limited to those undertaking international travel, purchasers will need to apply a discount code which can initially be obtained from airlines when booking travel.
Those passengers wishing to order a Randox PCR COVID-19 home test should visit: https://www.randoxhealth.com/covid-19-home-testing-kit/
Randox have been active in Covid-19 testing since early 2020, and currently have the largest Covid-19 testing network within the UK.
The Department of Transport report, produced by the Global Travel Taskforce and released on 9th April, shows how international travel could resume from 17 May 2021 at the earliest, in an accessible and affordable way. This includes the removal of the permission to travel form – meaning passengers would no longer need to prove they have a valid reason to leave the country.
The UK is a global leader in genome sequencing, which in positive cases allows the identification of variants of concern.
The risks posed by these variants remain significant, and restrictions for inbound passengers, such as 10-day managed quarantine, home quarantine, and stringent testing will remain in place – but will apply to people differently depending on whether the destination visited is categorised as ‘green’, ‘amber’ or ‘red’.
Green: arrivals will need to take a pre-departure test as well as a polymerase chain reaction (PCR) test on or before day 2 of their arrival back into the UK – but will not need to quarantine on return (unless they receive a positive result) or take any additional tests, halving the cost of tests on their return from holiday
Amber: arrivals will need to quarantine for a period of 10 days and take a pre-departure test, and a PCR test on day 2 and day 8 with the option for Test to Release on day 5 to end self-isolation early
Red: arrivals will be subject to restrictions currently in place for ‘red list’ countries which include a 10-day stay in a managed quarantine hotel, pre-departure testing and PCR testing on day 2 and 8
Testing remains an essential part of protecting public health as restrictions begin to ease – with all arrivals who are not exempt required to book a pre-departure, day 2 and day 8 test before travelling.
For further information on our £60 PCR test please contact the Randox Covid Customer Support team on email@example.com or 0800 2545 201.
For press enquiries please contact Amy Millar in the Randox PR team on firstname.lastname@example.org or 028 9442 2413
Randox in the media
Saturday 10th April 2021: Rachael Blackmore wins the Randox Grand National 2021 on Minella Times
Rachael Blackmore made history when she became the first female jockey to win the Randox Grand National, on Saturday 10th April 2021.
Upon Henry de Bromhead-trained Minella Times, owned by JP McManus, the odds of a victory for Rachael were 11-1.
Blackmore and Minella Times rode over 30 fences and were first past the post in the 2021 running of the world’s greatest and most famous horse race, beating Balko Des Flos, who finished second, by six and a half lengths.
“I just cannot believe it,” Rachael said.
“I don’t feel male or female right now, I don’t even feel human!”
Unfortunately there were no crowds at Aintree racecourse this year, in light of restrictions relating to the Covid-19 pandemic, but Blackmore was cheered on by owners, trainers, stable staff and racing officials.
An audience of 8.8 million tuned in to ITV to watch Rachael’s historic win onboard Minella Times.
Dickon White, Regional Director for Jockey Club Racecourses said;
“Minella Times, Rachael Blackmore and Henry d Bromhead have given us a story for the ages and I’m grateful that ITV have helped to ensure it inspires people across our society that it doesn’t matter who you are or where you’re from, if you have a dream you should go for it.”
To mark Rachael’s historic win in the Randox Grand National, Randox Health are offering 20% off all health check programmes, until Sunday 18th April. Visit randoxhealth.com to find out more.
For further information please email Amy Millar in the Randox PR team on email@example.com or 028 9442 2413
Randox in the media
09TH APRIL 2021: THE 12 MILLION MILESTONE
We are pleased to let you know that on 09th April 2021, Randox processed its 12 millionth sample within the UK COVID-19 National Testing Programme.
That’s an incredible 12 million samples processed by our dedicated and talented staff.
Our staff are our best asset and have risen to the challenge this pandemic has created.
They have worked hard and flexibly, been creative and innovative, and pulled together as a team to make an impact in the fight against COVID-19.
We are very proud of their efforts and teamwork.
Let us once again say thank you to each and every member of Team Randox, for the efforts they have made.
We continue to work hard and improve, for the sake of our family, friends and communities.
For further information please email firstname.lastname@example.org
Randox in the media
7th April 2021
Building a fairer, healthier world
World Health Day is a global health awareness day celebrated every year on 7th April, under the sponsorship of the World Health Organisation (WHO) who sees it as an opportunity to draw worldwide attention to a subject of major importance to global health. Each year is related to a particular theme and this year’s focus is “building a fairer, healthier world”.
In view of the ongoing global COVID-19 pandemic where restrictions remain in place across most parts of the world, this time has highlighted that some people are able to live healthier lives and have better access to health services than others. COVID-19 has hit all countries hard, but its impact has been harshest on those communities which were already vulnerable, who are more exposed to the disease, less likely to have access to quality health care services and more likely to experience adverse consequences as a result of measures implemented to contain the pandemic, placing additional stress on healthcare systems across the world.
The COVID-19 pandemic has disrupted and even halted particular health services with most countries (90%) reporting that many routine and elective services have been suspended, while critical care – such as cancer screening and treatment and HIV therapy has seen high-risk interruptions (WHO, 2020).
“the enjoyment of the highest attainable standard of health is one of the fundamental rights of every human being without distinction of race, religion, political belief, economic or social condition.” (WHO, 2021).
Randox has adapted to the emergence of the COVID-19 pandemic by developing pioneering tests to diagnose COVID-19, offering a range of COVID-19 testing solutions using Randox’s patented Biochip Technology capable of conducting multiple tests simultaneously on a range of molecular testing platforms, with results available from the Vivalytic, Evidence Investigator and Randox Discovery.
With a game-changing global partnership formed between Randox Laboratories and Bosch Healthcare Solutions combining science and technology, successfully launching the Vivalytic – the all in one solution for molecular diagnostics, the Vivalytic has been designed against the challenges posed by climate change and to contribute towards sustainability. The Vivalytic cartridges are CO2 neutral – this means that emissions that are in our direct sphere of influence are neutralised – making a further contribution to climate protection.
Furthermore, Randox’s vision is to improve healthcare worldwide and to ensure physicians and the public have access to the latest advancements in clinical diagnostics to aid diagnosis, treatment, and management of patients. Randox offer a comprehensive biochip test menu to support and combat challenges facing global health on an everyday basis from testing for Chronic Lung Disease (CLD) to predicting Alzheimers Disease. View Randox’s full Biochip Technology Immunoassay test menu here.
Please contact email@example.com for further information on any of the mentioned above.
Randox in the media
Randox Grand National 2021 trophy pays tribute to COVID pandemic key workers
Saturday 3rd April 2021
The headline sponsor of the Randox Grand National has unveiled the trophy for the 2021 event with a tribute to key workers of the COVID-19 pandemic.
Shown to the public for the first time on Saturday 3rd April during ITV Racing’s Opening Show, the 2021 trophy has been designed for the second year by Silversmith Cara Murphy from Northern Ireland.
The unique design of the silver and gold trophy, which includes illustrations of the COVID-19 virus on its base, acknowledges a historic year and the collective efforts of all key workers during this time.
Dr Peter FitzGerald, Randox Managing Director, said;
“It is only fitting that the trophy for the 2021 Randox Grand National recognises the momentous impact COVID-19 has had on all of our lives, and we pay tribute to the incredible dedication and sacrifice of all key workers in fighting the coronavirus.
“In establishing and running the largest throughput COVID-19 laboratory in the UK, Randox staff have stood shoulder to shoulder with our colleagues in the NHS and elsewhere, and we salute their commitment and achievements.
“As we reflect on the year gone by, and importantly, look ahead to the future, it will be vital that we take forward the lessons we have learnt from the pandemic – the importance of early and accurate testing and the role diagnostic technology can play in meeting future health challenges.
“I believe the 2021 Randox Grand National trophy will serve as a reminder of this message, and of the truly important things in life – our friends, our family, and our health.”
In recognition of Randox’s role in the UK National Testing Programme, the 2021 Randox Grand National trophy features an intricate stem made of the DNA double helix that forms the basis of the testing methods used to detect COVID-19.
At the head of the stem is a striking sphere to signify the circle of Randox’s corporate logo that has become synonymous with a blood drop on which so many of the company’s health tests, including those within Randox Health’s world-leading health checks, are conducted.
Silversmith Cara Murphy commented;
“This has been a tough year for everyone and it has been an honour to work with Randox to create the 2021 Randox Grand National trophy to commemorate the incredible and dedicated efforts of Randox staff in the UK’s National COVID-19 Testing Programme.
“Whilst we are unable to meet together in person for the 2021 Randox Grand National, their hard work has played such a key role in bringing us to a more positive place and one step closer to normality.
“In years to come the winner of this year’s trophy will look at the COVID virus engraving on its base and be able to reflect not only on their success in the Randox Grand National, but on the incredible challenges and achievements of these times.”
Another popular element returning for the 2021 Randox Grand National are the team trophies. In their first year as sponsor, Randox introduced the concept of presenting the entire winning team with individual trophies, to celebrate the combined effort that goes in to achieving such a special victory.
For further enquiries please contact Amy Millar in the Randox PR team: firstname.lastname@example.org or 028 9442 2413
Randox in the media
29 March 2021
Belfast City Airport Announces Covid Testing Centre with Randox
Belfast City Airport has announced an onsite covid testing centre in partnership with leading global diagnostics firm, Randox, in preparation for the return of its international flights in the coming months.
The centre will offer both PCR tests and antigen (lateral flow) tests and will give passengers access to quick and safe testing.
Judith Davis, Airport Operations Manager at Belfast City Airport, said:
“The PCR and antigen tests are a current requirement for passengers heading to the Netherlands, and with our KLM flights due to recommence over the next month, it is imperative that we have the testing facilities in place to enable those travelling for essential reasons to be able to do so in a convenient manner.
“The testing facilities will also help with forward planning for those who are connecting through major hub airports, such as Manchester and London Heathrow, or travelling to sunshine destinations with our new airline partner, Ryanair, allowing them to take the test before they leave Northern Ireland.”
Belfast City Airport was recently the first airport in Northern Ireland to achieve the ACI’s Airport Health Accreditation for its extensive and thorough health and safety measures, such as sanitising stations throughout the terminal and requiring anyone entering to wear a face covering.
“The safety of our passengers and staff is at the forefront of our operations and those travelling to the Airport can be reassured that stringent measures are in place” Judith concluded.
David Adamson, Regional Manager at Randox Laboratories, said:
“Along the roadmap out of lockdown, testing will remain a key part of the response to COVID-19 – not only to identify cases and prevent further spread, but also to assist with a return to social and economic normality. The Randox Health Travel Centre at Belfast City Airport, providing accurate and cost-effective antigen and gold standard PCR testing, is another positive step towards the normalization of travel.
“We are pleased to be working with the airport to support their enormous efforts to restore public confidence in international travel and to get people back in the air again if and when they are required to do so.”
Work for the test centre is already underway, with H&J Martin Asset Management Services completing the fit out to include a resting area for passengers who have taken their test, and is expected to be completed over the coming weeks.
For further information please contact Amy Millar in the Randox Public Relations team; email@example.com or 028 9442 2413
Randox Health offers a range of COVID-19 testing services for fit to fly, test to release, workplace testing or simply for peace of mind.
Order a home sample collection kit, book an appointment at a Randox Health Travel Centre (available in the UK and Ireland) or visit a Randox Mobile Laboratory (located at Heathrow and Liverpool Airports).
COVID-19 antibody testing is available in Randox Health Clinics.
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
25th MARCH 2021
Northern Ireland Chamber of Commerce and Industry (NI Chamber) has announced that Randox, the UK and Ireland’s largest diagnostics company, is its newest Patron organisation.
As a new NI Chamber Patron, Randox joins a select group of leading businesses, who lend their support to the development of the region’s economy and business community. The partnership offers mutual benefit and will see Randox experience increased brand exposure among the business community and close association with a leading membership organisation.
Announcing the partnership, Ann McGregor, Chief Executive, NI Chamber said:
“Randox has a long relationship with NI Chamber and I am delighted to announce that the company has decided to strengthen its association with us, by coming on board as a Patron.
“Having the support of one of Northern Ireland’s leading exporters is a real endorsement of the work we do and in particular, the support NI Chamber has provided to companies over the past 12 months. As we continue to help firms in all sectors to restart and grow, we look forward to working with Randox and indeed all of our Patrons.”
Dr Peter FitzGerald, Managing Director of Randox, added:
“We are delighted to be welcomed as a patron of Northern Ireland Chamber of Commerce and Industry. As a leading life science company with global export markets, Randox very much values the contribution of the Chamber – particularly so at a time of significant change related to Brexit and the impact of COVID-19. We are ambitious for the future and see the potential for significant growth, as the importance of diagnostics and preventative healthcare grows. We look forward to working with Ann and the Chamber team as we rise to meet the challenges and seize the opportunities to grow our economy – for the benefit of all our people.”
Established in 1982, Randox is the largest diagnostics company from the UK and Ireland; focusing on the provision of accurate and timely health testing. By identifying risk to health, improving clinical diagnoses and promoting preventative healthcare, Randox technologies are used to achieve better health outcomes whilst reducing the burden on clinical services. The company’s innovative and comprehensive portfolio includes tests for diabetes, Alzheimer’s disease, cancer, stroke and COVID-19. In 2019 Randox manufactured over 4 billion tests, and operated in 145 countries. With over 2000 staff, including more than 450 research scientists and engineers, key facilities are located in Co Antrim and Co Donegal.
Randox joins a list of NI Chamber Patrons which also includes Caterpillar, Danske Bank, DSV, fonaCAB, Investec, Moy Park, Pinsent Masons, Power NI, Queen’s University, Ulster Bank, Ulster Carpets and Ulster University Business School.
For further information please email Amy Millar, Public Relations Team Leader on firstname.lastname@example.org or 028 9442 2413